Ajanta Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE031B01049
  • NSEID: AJANTPHARM
  • BSEID: 532331
INR
3,316.65
46.4 (1.42%)
BSENSE

Nov 20

BSE+NSE Vol: 89.46 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
1,794.16
1,625.96
1,421.64
1,374.84
1,353.73
1,302.65
1,170.41
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,794.16
1,625.96
1,421.64
1,374.84
1,353.73
1,302.65
1,170.41
Raw Material Cost
348.97
296.51
256.76
235.07
217.60
207.08
190.96
Purchase of Finished goods
80.89
66.92
71.35
53.55
53.26
51.63
80.18
(Increase) / Decrease In Stocks
-44.75
-35.58
-23.30
-2.36
45.95
17.17
12.28
Employee Cost
383.69
381.11
340.72
330.52
317.01
302.90
279.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
477.80
493.42
442.70
375.82
392.08
372.52
310.06
Total Expenditure (Excl Depreciation)
1,246.60
1,202.38
1,088.23
992.60
1,025.90
951.30
873.26
Operating Profit (PBDIT) excl Other Income
547.56
423.58
333.41
382.24
327.83
351.35
297.15
Other Income
37.39
70.90
61.43
24.97
59.34
26.33
18.11
Operating Profit (PBDIT)
584.95
494.48
394.84
407.21
387.17
377.68
315.26
Interest
2.24
3.18
2.36
5.10
3.39
5.26
6.07
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
582.71
491.30
392.48
402.11
383.78
372.42
309.19
Depreciation
47.56
44.50
45.37
43.51
42.97
41.29
39.78
Profit Before Tax
535.15
446.80
347.11
358.60
340.81
331.13
269.41
Tax
147.01
112.58
80.41
84.83
80.62
75.79
44.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
388.14
334.22
266.70
273.77
260.19
255.34
225.26
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
388.14
334.22
266.70
273.77
260.19
255.34
225.26
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
388.14
334.22
266.70
273.77
260.19
255.34
225.26
Equity Capital
25.07
25.07
25.07
25.07
25.07
25.07
25.07
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
30.96
26.66
21.28
21.84
20.76
20.37
17.97
Diluted Earnings per share
31.07
26.72
21.34
21.91
20.82
20.43
18.0
Operating Profit Margin (Excl OI)
30.52%
26.05%
23.45%
27.8%
24.22%
26.97%
25.39%
Gross Profit Margin
32.48%
30.22%
27.61%
29.25%
28.35%
28.59%
26.42%
PAT Margin
21.63%
20.56%
18.76%
19.91%
19.22%
19.6%
19.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 32.53% vs 14.08% in Sep 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2026 is 49.18% vs 20.19% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 67.03% vs 5.35% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is -33.92% vs -43.69% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025

Compare Quarterly Results Of Ajanta Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,794.16
2,820.47
-1,026.31
-36.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,794.16
2,820.47
-1,026.31
-36.39%
Raw Material Cost
348.97
642.13
-293.16
-45.65%
Purchase of Finished goods
80.89
625.41
-544.52
-87.07%
(Increase) / Decrease In Stocks
-44.75
-125.17
80.42
64.25%
Employee Cost
383.69
434.71
-51.02
-11.74%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
477.80
655.55
-177.75
-27.11%
Total Expenditure (Excl Depreciation)
1,246.60
2,232.64
-986.04
-44.16%
Operating Profit (PBDIT) excl Other Income
547.56
587.83
-40.27
-6.85%
Other Income
37.39
3.25
34.14
1,050.46%
Operating Profit (PBDIT)
584.95
591.08
-6.13
-1.04%
Interest
2.24
35.58
-33.34
-93.70%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
582.71
555.50
27.21
4.90%
Depreciation
47.56
109.66
-62.10
-56.63%
Profit Before Tax
535.15
445.85
89.30
20.03%
Tax
147.01
120.78
26.23
21.72%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
388.14
325.07
63.07
19.40%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
388.14
325.07
63.07
19.40%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-0.50
0.50
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
388.14
325.57
62.57
19.22%
Equity Capital
25.07
189.71
-164.64
-86.79%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
30.96
17.16
13.80
80.42%
Diluted Earnings per share
31.07
17.14
13.93
81.27%
Operating Profit Margin (Excl OI)
30.52%
20.84%
0.00
9.68%
Gross Profit Margin
32.48%
19.70%
0.00
12.78%
PAT Margin
21.63%
11.53%
0.00
10.10%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,794.16 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 10.34% vs 14.37% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 32.53% vs 14.08% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 388.14 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 16.13% vs 25.32% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 49.18% vs 20.19% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 547.56 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 29.27% vs 27.04% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 67.03% vs 5.35% in Sep 2025

Quarterly - Interest
Interest 2.24 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -29.56% vs 34.75% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -33.92% vs -43.69% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.52%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025